Effect of preoperative programmed death-1 or programmed death ligand-1 immune check point inhibition on complications after surgery for primary head and neck cancer.

Ramez H W PhilipsAngela AlnemriDev AminJena PatelMichael C TopfJennifer M JohnsonVoichita BarAdRita AxelrodAthanassios ArgirisChristopher FundakowskiAdam J LuginbuhlDavid M CognettiJoseph M Curry

Published in: Cancer (2023)

It is safe to give immunotherapy before major surgery in patients who have head and neck cancer. Advanced age, non-White race, current/former smoking, free flap surgery, and perineural invasion may be associated with increased the odds of surgical complications.

Keyphrases

minimally invasive
coronary artery bypass
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
risk factors
percutaneous coronary intervention
smoking cessation
acute coronary syndrome